低剂量维里西瓜特在心力衰竭中与减少的喷射分数:一个病例报告
1Cardiology, North Cumbria Integrated Care, Whitehaven, GBR.
Cureus
|January 21, 2026
概括
低剂量输送剂改善了心力衰竭患者的症状,并减少了心力衰竭患者的住院治疗. 这种辅助疗法显示出没有副作用的益处,这表明潜在的HFrEF治疗未得到充分利用.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 降低射出分数 (HFrEF) 的心力衰竭仍然是一个重要的临床挑战,尽管有指导方针导向的医疗治疗,但结果仍不理想.
- 维瑞西瓜特是一种可溶性酸环酶刺激剂,已被批准作为HFrEF的辅助疗法,但未得到充分利用.
- 这份病例报告涉及低剂量输送的临床实用性,该实用性在患者中具有恶化的HFrEF症状.
研究的目的:
- 描述在患者中开始低剂量输血剂的临床益处. 在患者中开始低剂量输血剂.
- 为了评估 vericiguat 的安全性和有效性,当由于患者特定因素而没有升级标位时.
主要方法:
- 一份病例报告显示,一名78岁的男性患有因缺血性心肌病而导致的二次性HFrEF.
- 由于对边界低血压和功能恶化的担忧,每天开始服用2.5毫克的 vericiguat.
- 临床评估包括纽约心脏协会 (NYHA) 的功能类,左心室喷射率 (LVEF),功能和住院率.
主要成果:
- 患者经历了显著的症状改善,NYHA类从III提高到I.
- 在随访期间,左心室喷射分数 (LVEF) 增加,与心力衰竭相关的住院病例减少.
- 功能保持稳定,没有观察到低血压或电解质异常等不良事件.
结论:
- 在特定的HFrEF患者中,低剂量输血剂可能提供临床益处,包括改善功能状态和减少住院治疗.
- 这种辅助疗法似乎是安全有效的,即使没有升级,也没有对功能产生负面影响.
- 需要进行进一步的研究,以确定低剂量输送器的长期安全性和有效性,在不同的HFrEF群体中.
相关概念视频
01:11Renal Failure: Dose Adjustments
442
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
442
01:29Heart Failure II: Pathophysiology
783
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
783
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
723
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723
01:22Heart Failure VI: Adjunct Therapies
277
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
277
01:22Heart Failure Drugs: Diuretics
824
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
824